more than 20 years of experience in mature and emerging markets delivering significant business results through Market access, public - private partnerships, medical and governmental affairs initiatives. strong R&D background in oncology, pain and supportive care as well as modified-release dosage forms. extensive academic experience in Pharmacokinetics & Pharmacodynamics, Pharmaceutical Technology, Clinical Pharmacy, Ethics and pharmaceutical regulation (registration and Market access). self-starter and creative problem solver, passionate by shaping payer/stakeholder perception through development of sound value propositions for Healthcare products and services. proven superior Negotiation skills. stimulated by complex and multicultural environment. strategic Leader with an eye for detail.
Independent Director, Board of Directors
Since January 2015
on january 2015, the integrated biobank of luxembourg and the centre de recherche public- santé were merged into a new entity called luxembourg institute of Health. the luxembourg institute of Health is a public Research centre under the "loi du 03 décembre 2014 ayant pour objet l'organisation des centres de recherche publics". the Board of Directors oversees both ibbl and former crp-santé activities. On January 2015, the Integrated Biobank of Luxembourg and the Centre de Recherche Public- Santé were merged into a new entity called Luxembourg Institute of Health. The Luxembourg Institute of Health is a Public Research Centre under the "Loi du 03 décembre 2014 ayant pour objet l'organisation des centres de recherche publics". The Board of Directors oversees both IBBL and former CRP-Santé activities.
Since December 2014
management centre europe (mce) is the largest provider of Strategy implementation and business transformation programmes for international companies, wherever they have Operations. management consultancies usually only design strategies and reengineer processes. mce is different. we enable individual managers and management teams to deliver on their strategic goals. to do this, we provide them with the necessary functional and cross-functional capabilities to measurably improve performance. Management Centre Europe (MCE) is the largest provider of strategy implementation and business transformation programmes for international companies, wherever they have operations. Management consultancies usually only design strategies and reengineer processes. MCE is different. We enable individual managers and management teams to deliver on their strategic goals. To do this, we provide them with the necessary functional and cross-functional capabilities to measurably improve performance.
Since June 2013
based in lucerne, alpine partners is a boutique Consulting firm specializing in Healthcare Innovation. we provide a large set of services and expertise in the fields of Market access (registration, Pricing and Reimbursement), public-private partnerships, medical/scientific affairs, Training/Coaching and Marketing Strategy. our clients are global Healthcare companies (Pharmaceuticals, Medical Devices, Diagnostics and consumer goods), mid-sized biotech firms, governmental bodies and ngos. Based in Lucerne, Alpine Partners is a boutique consulting firm specializing in healthcare innovation. We provide a large set of services and expertise in the fields of Market Access (registration, pricing and reimbursement), Public-Private Partnerships, Medical/Scientific Affairs, Training/coaching and Marketing Strategy. Our clients are global healthcare companies (pharmaceuticals, medical devices, diagnostics and consumer goods), mid-sized biotech firms, governmental bodies and NGOs.
Since June 2013
pharmed is a post-graduate course in Pharmaceutical medicine/medicines development sciences. Pharmaceutical medicine is classically defined as the medical scientific discipline concerned with the discovery, development, evaluation, registration, monitoring and medical aspects of Marketing of medicines for the benefit of patients and Public Health. the pharmed programme covers the entire process of Drug Development from Drug Discovery to Market access. the purpose of pharmed is to provide a specific Training for the various functions held in Pharmaceutical companies, cros and regulatory agencies by physicians, Pharmacists, doctors in Veterinary Medicine and masters and phds in Life Sciences. PHARMED is a post-graduate course in pharmaceutical medicine/medicines development sciences. Pharmaceutical medicine is classically defined as the medical scientific discipline concerned with the discovery, development, evaluation, registration, monitoring and medical aspects of marketing of medicines for the benefit of patients and Public Health. The PHARMED programme covers the entire process of drug development from drug discovery to market access. The purpose of PHARMED is to provide a specific training for the various functions held in pharmaceutical companies, CROs and regulatory agencies by physicians, pharmacists, doctors in veterinary medicine and masters and PhDs in life sciences.
Independent Director, Board of DirectorsJune 2013 --- December 2014
the integrated biobank of luxembourg is an independent biobanking and Biotechnology organization designed to facilitate Medical Research in luxembourg and to participate in bringing the next generation of Healthcare to its citizens. we collect, store, and analyze Biological samples and associated data, which are then made available to research organizations investigating new Diagnostics and treatments for diseases. together with our public and private partners, we hope to catalyze research that translates today’s discoveries into tomorrow’s Healthcare solutions.
Divisional Director, Global Value Proposition, EPD HQDecember 2011 --- March 2013
Market access Leadership team Member, reporting to the global head of Market access Member of the emea west Leadership team, dotted-line reporting to the area vice-President emea-w* core job responsibilities: - define epd global value proposition versus pure generics, analyze potential value dimensions and Hypothesis - collaborate with external opinion leaders and Research groups to generate Public Health evidences to sustain value claims - design and execute outcomes Research projects and initiatives to support the value proposition - provide guidance on related Health Policy platform engagement in close collaboration with government affairs colleagues, country gms and area vps - monitor Health Policy environment, anticipate trend and changes, proactively adjust and adapt epd value proposition and related activities - provide strategic input into portfolio optimization to support/enhance epd value proposition * support the country separation process for emea-w providing guidance for the newly created country and area level Market access & policy structure
Legal & Chief Representative, ChinaJanuary 2009 --- December 2011
supervised all c-map Operations (the first ppp between msd and the government of china) with a team of 30 people in 3 offices (beijing, chengdu, xichang), 130 implementing agencies and annual budget of 7 million usd
Head, Public Policy & HEOR (later Public Policy & Market Access), ChinaJanuary 2009 --- December 2011
country management team Member, reporting to the Chairman and President msd china health outcomes: managed and coached a team of 7 people who develop and implement outcomes Research studies and initiatives supporting key Therapeutic Areas (id, Diabetes, Ophthalmology, cv, Respiratory, Vaccines, oncology) major achievements: - developed and implemented one of the largest real world outcomes study for patients with type 2 Diabetes (acronym: 3b, 25000 patients) and its extension public policy: led a team of 3 people to develop, launch and implement innovative multi-year public-private partnerships in id and cv-Metabolism major achievements: -partnership with the sichuan health bureau on integrated and standardized management of Hypertension, dyslipidemia, and type 2 Diabetes (target population for pilot phase: 2 million inhabitants) -partnership with china center for disease control and prevention on viral hepatitis (includes health outcomes Research, medical and public Education, Health Policy advocacy) -several partnerships with city governments on chronic disease management
Member, Scientific Advisory BoardJanuary 1997 --- January 2009
founding Member of the scientific advisory board and speaker. sémiologie dermatologique la douleur, aspects neurophysiologiques, cliniques et traitement traitement pharmacologique du patient cancéreux céphalées de tension et céphalées induites les coxibs pathologies et douleurs digestives arthrite rhumatoïde rhinite allergique et son impact sur l'asthme
Independant ConsultantJanuary 1993 --- January 2005
corporate consultancy in medical affairs (Medical Education, kol's engagement plans and Phase IV study Planning and execution). key clients: orthobiotech (raritan, nj, us) and janssen-cilag (berchem, belgium), roche, msd, glaxo smithkline, boots Healthcare, laboratoires upsa (subsidiary of bristol myers squibb), therabel institutional consultancy in belgium: - titular Member of the belgian center for pharmacotherapeutic information, ministry of Health - Member of the sspf’s scientific advisory board (French-speaking Pharmacists scientific society) - founding President of the pain advisory board (multidisciplinary approach of pain Treatment) - invited Member of the superior hygiene council, ministry of Health
LinkedIn Assessment :
Executive Master in Healthcare Management (MMISS) in Hospital and Health Care Facilities Administration/Management from Solvay Brussels School in 2016
Negotiation Dynamics Executive Programme in Negotiations from INSEAD in 2007
Critical Issues in Tumor Microcirculation, Angiogenesis and Metastasis in Oncology and Cancer Biology from Harvard Medical School in 2001
PhD in Pharmaceutical Sciences from Université libre de Bruxelles in 1999
Master in International Politic from Université libre de Bruxelles in 1996
Visiting Scientist in Pharmaceutical Sciences from Università degli Studi di Parma in 1994
PharmD in Pharmacy from Université libre de Bruxelles in 1993
in from Athénée Royal Jourdan in 0000
Area / Region